Candesartan Cilexetil + Hydrochlorothiazide

680+80 mg Chewable Tablet

680+80 mg/5 ml, 100 ml Oral Suspension

1200+140+300 mg/10 ml, 100 ml Oral Suspension

500 mg Capsule

8, 16, 32 mg Tablet

16 + 10 mg, 16 + 5 mg, 32 + 10 mg, 32 + 5 mg, 8 + 2.5 mg, 8 + 5 mg Tablet

25, 50 mg Tablet

50, 70 mg (IV) Vial Containing Lyophilized Powder for Infusion

250, 500, 1000 mg (IM) Injectable (vial)

250, 500, 1000 mg (IV/IM) Injectable (vial)

600 mg Film Coated Tablet

300 mg Capsule

Deva EU Markets Product List

Our product portfolio contains more than 650 products in 14 therapeutic areas, ranging from oncology to cardiology, respiratory system and ophthalmology, as well as medical devices.

Currently, its product portfolio contains more than 650 products in 14 therapeutic areas, ranging from oncology to cardiology, respiratory system and ophthalmology, as well as medical devices.

Currently, its product portfolio contains more than 650 products in 14 therapeutic areas, ranging from oncology to cardiology, respiratory system and ophthalmology, as well as medical devices.